Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)

SHE:002755 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	1,232	1,422	1,411	1,047	772.71	1,166
Trading Asset Securities	1,194	1,059	683.28	713.83	839.08	522.39
Cash & Short-Term Investments	2,426	2,481	2,095	1,761	1,612	1,688
Cash Growth	-1.99%	18.43%	18.96%	9.25%	-4.51%	14.90%
Accounts Receivable	183.74	279.17	231.83	181.24	323.03	581.86
Other Receivables	4.71	6.77	13.02	49.88	25.21	16.29
Receivables	188.45	285.94	244.85	231.12	348.23	598.15
Inventory	114.21	124.55	196.99	167.49	141.53	141.84
Other Current Assets	28.05	99.24	31.59	27	36.56	59.14
Total Current Assets	2,757	2,991	2,568	2,186	2,138	2,487
Property, Plant & Equipment	374.39	415.06	474.03	478.4	547.14	658.33
Long-Term Investments	45.65	47.61	118.72	118.21	107.57	105.18
Other Intangible Assets	546.84	578.89	146.34	98.34	95.77	97.69
Long-Term Deferred Tax Assets	36.78	24.65	24.62	25.73	25.85	28.69
Long-Term Deferred Charges	585.79	423.1	676.78	563.46	453.7	342.02
Other Long-Term Assets	35.07	37.26	38.97	53.26	46.22	5.75
Total Assets	4,382	4,517	4,048	3,524	3,414	3,725

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	35.18	121.07	59.98	38.29	39.08	65.72
Accrued Expenses	7.24	34	40.84	43.6	119.56	133.48
Short-Term Debt	30	27	62	114.02	45.03	-
Current Portion of Leases	2.54	2.79	4.06	3.03	3.45	2.61
Current Income Taxes Payable	24.43	34.18	2.05	3.59	2.13	7.54
Current Unearned Revenue	217.28	283.61	108.51	15.88	11.68	15.26
Other Current Liabilities	633.45	664.17	543.53	213.14	102.81	177.11
Total Current Liabilities	950.12	1,167	820.96	431.55	323.74	401.71
Long-Term Leases	3.82	4.04	6.62	6.75	8.92	11.52
Long-Term Unearned Revenue	63.21	56.1	60.66	64.72	55.81	68.93
Long-Term Deferred Tax Liabilities	16.01	16.01	17.15	10.18	12.56	15.08
Total Liabilities	1,033	1,243	905.39	513.2	401.03	497.24

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	928.16	928.16	928.16	928.16	928.16	928.16
Additional Paid-In Capital	163.64	163.64	136.94	136.94	50.73	0.94
Retained Earnings	2,172	2,114	1,989	1,828	1,977	2,295
Comprehensive Income & Other	12.84	9.78	8.95	6.58	7.25	-5.9
Total Common Equity	3,276	3,215	3,063	2,900	2,963	3,219
Minority Interest	72.08	58.71	79.59	110.7	50.37	8.82
Shareholders' Equity	3,349	3,274	3,142	3,011	3,013	3,228
Total Liabilities & Equity	4,382	4,517	4,048	3,524	3,414	3,725

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	36.36	33.83	72.67	123.8	57.41	14.13
Net Cash (Debt)	2,390	2,447	2,022	1,637	1,554	1,674
Net Cash Growth	-1.34%	21.01%	23.52%	5.32%	-7.14%	15.51%
Net Cash Per Share	2.50	2.59	2.14	1.76	1.65	1.81
Filing Date Shares Outstanding	928.16	928.16	928.16	928.16	928.16	928.16
Total Common Shares Outstanding	928.16	928.16	928.16	928.16	928.16	928.16
Working Capital	1,807	1,824	1,747	1,755	1,814	2,085
Book Value Per Share	3.53	3.46	3.30	3.12	3.19	3.47
Tangible Book Value	2,730	2,637	2,916	2,802	2,867	3,121
Tangible Book Value Per Share	2.94	2.84	3.14	3.02	3.09	3.36
Buildings	-	385.99	385.96	375.5	371.29	437.94
Machinery	-	803.98	804.36	744.21	767.2	776.51
Construction In Progress	-	29.85	23.51	36.07	29.8	19.71

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error